AMN
AMN Healthcare Services, Inc.
Medical - Care Facilities
Market Cap$869M
5Y Perf.-49.3%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
AMN vs HCSG
Revenue, margins, valuation, and 5-year total return — side by side.
HCSG
Healthcare Services Group, Inc.
Medical - Care Facilities
Market Cap$1.60B
5Y Perf.-6.7%
AMN vs HCSG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | AMN | HCSG |
|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $869M | $1.60B |
| Revenue (TTM) | $3.42B | $1.84B |
| Net Income (TTM) | $-32M | $59M |
| Gross Margin | 25.5% | 13.3% |
| Operating Margin | 0.3% | 3.0% |
| Forward P/E | 11.0x | 20.8x |
| Total Debt | $803M | $25M |
| Cash & Equiv. | $34M | $161M |
AMN vs HCSG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
AMN
HCSG
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| AMN Healthcare Serv… (AMN) | 100 | 50.7 | -49.3% |
| Healthcare Services… (HCSG) | 100 | 93.3 | -6.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMN vs HCSG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: HCSG leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. AMN Healthcare Services, Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
AMN
AMN Healthcare Services, Inc.
The Income Pick
AMN is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 1.08
- Lower volatility, beta 1.08, current ratio 0.94x
- Beta 1.08, current ratio 0.94x
Best for: income & stability and sleep-well-at-night
HCSG
Healthcare Services Group, Inc.
The Growth Play
HCSG carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 7.1%, EPS growth 52.8%, 3Y rev CAGR 2.8%
- -26.8% 10Y total return vs AMN's -41.5%
- 7.1% revenue growth vs AMN's -8.5%
Best for: growth exposure and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | HCSG | 7.1% revenue growth vs AMN's -8.5% |
| Value | AMN | Lower P/E (11.0x vs 20.8x) |
| Quality / Margins | HCSG | 3.2% margin vs AMN's -0.9% |
| Stability / Safety | AMN | Beta 1.08 vs HCSG's 1.12 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | HCSG | +55.8% vs AMN's +14.6% |
| Efficiency (ROA) | HCSG | 7.3% ROA vs AMN's -1.4%, ROIC 9.0% vs 1.6% |
AMN vs HCSG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
AMN vs HCSG — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLAMNLAGGINGHCSG
HCSGHealthcare Services G…
2leads
AMNAMN Healthcare Servic…
3leads
6 Total Categories
CATEGORYLEADERvs HCSGMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
AMN4/6
Valuation MetricsMultiples, price ratios, and targets
AMN6/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
HCSG9/9
Total Returns1Y, 3Y, 5Y total returns with dividends
HCSG5/6
Risk & VolatilityBeta, volatility, and downside exposure
AMN2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
AMN leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMN is the larger business by revenue, generating $3.4B annually — 1.9x HCSG's $1.8B. Profitability is closely matched — net margins range from 3.2% (HCSG) to -0.9% (AMN). On growth, AMN holds the edge at +99.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | AMNAMN Healthcare Se… | HCSGHealthcare Servic… |
|---|---|---|
| RevenueTrailing 12 months | $3.4B | $1.8B |
| EBITDAEarnings before interest/tax | $127M | $72M |
| Net IncomeAfter-tax profit | -$32M | $59M |
| Free Cash FlowCash after capex | $714M | $139M |
| Gross MarginGross profit ÷ Revenue | +25.5% | +13.3% |
| Operating MarginEBIT ÷ Revenue | +0.3% | +3.0% |
| Net MarginNet income ÷ Revenue | -0.9% | +3.2% |
| FCF MarginFCF ÷ Revenue | +20.9% | +7.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +99.9% | +6.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +56.8% | +175.0% |
AMN leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
AMN leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, AMN's 8.6x EV/EBITDA is more attractive than HCSG's 22.4x.
| Metric | AMNAMN Healthcare Se… | HCSGHealthcare Servic… |
|---|---|---|
| Market CapShares × price | $869M | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $1.6B | $1.5B |
| Trailing P/EPrice ÷ TTM EPS | -9.06x | 27.54x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.05x | 20.83x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 8.63x | 22.38x |
| Price / SalesMarket cap ÷ Revenue | 0.32x | 0.87x |
| Price / BookPrice ÷ Book value/share | 1.35x | 3.19x |
| Price / FCFMarket cap ÷ FCF | 3.72x | 11.49x |
AMN leads this category, winning 6 of 6 comparable metrics.
Profitability & Efficiency
HCSG leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-5 for AMN. HCSG carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMN's 1.25x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs AMN's 5/9, reflecting strong financial health.
| Metric | AMNAMN Healthcare Se… | HCSGHealthcare Servic… |
|---|---|---|
| ROE (TTM)Return on equity | -5.0% | +11.8% |
| ROA (TTM)Return on assets | -1.4% | +7.3% |
| ROICReturn on invested capital | +1.6% | +9.0% |
| ROCEReturn on capital employed | +2.0% | +7.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | 1.25x | 0.05x |
| Net DebtTotal debt minus cash | $769M | -$136M |
| Cash & Equiv.Liquid assets | $34M | $161M |
| Total DebtShort + long-term debt | $803M | $25M |
| Interest CoverageEBIT ÷ Interest expense | -1.70x | 33.02x |
HCSG leads this category, winning 9 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
HCSG leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HCSG five years ago would be worth $7,888 today (with dividends reinvested), compared to $2,488 for AMN. Over the past 12 months, HCSG leads with a +55.8% total return vs AMN's +14.6%. The 3-year compound annual growth rate (CAGR) favors HCSG at 14.1% vs AMN's -37.1% — a key indicator of consistent wealth creation.
| Metric | AMNAMN Healthcare Se… | HCSGHealthcare Servic… |
|---|---|---|
| YTD ReturnYear-to-date | +48.7% | +28.6% |
| 1-Year ReturnPast 12 months | +14.6% | +55.8% |
| 3-Year ReturnCumulative with dividends | -75.1% | +48.6% |
| 5-Year ReturnCumulative with dividends | -75.1% | -21.1% |
| 10-Year ReturnCumulative with dividends | -41.5% | -26.8% |
| CAGR (3Y)Annualised 3-year return | -37.1% | +14.1% |
HCSG leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
AMN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
AMN is the less volatile stock with a 1.08 beta — it tends to amplify market swings less than HCSG's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMN currently trades 94.7% from its 52-week high vs HCSG's 91.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | AMNAMN Healthcare Se… | HCSGHealthcare Servic… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.08x | 1.12x |
| 52-Week HighHighest price in past year | $23.74 | $24.39 |
| 52-Week LowLowest price in past year | $14.87 | $12.66 |
| % of 52W HighCurrent price vs 52-week peak | +94.7% | +91.5% |
| RSI (14)Momentum oscillator 0–100 | 57.2 | 61.8 |
| Avg Volume (50D)Average daily shares traded | 849K | 676K |
AMN leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates AMN as "Buy" and HCSG as "Hold". Consensus price targets imply 9.8% upside for HCSG (target: $25) vs 0.1% for AMN (target: $23).
| Metric | AMNAMN Healthcare Se… | HCSGHealthcare Servic… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $22.50 | $24.50 |
| # AnalystsCovering analysts | 17 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 20 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | +3.9% |
Insufficient data to determine a leader in this category.
Key Takeaway
AMN leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). HCSG leads in 2 (Profitability & Efficiency, Total Returns).
Best OverallAMN Healthcare Services, In… (AMN)Leads 3 of 6 categories
Loading custom metrics...
AMN vs HCSG: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is AMN or HCSG a better buy right now?
For growth investors, Healthcare Services Group, Inc.
(HCSG) is the stronger pick with 7. 1% revenue growth year-over-year, versus -8. 5% for AMN Healthcare Services, Inc. (AMN). Healthcare Services Group, Inc. (HCSG) offers the better valuation at 27. 5x trailing P/E (20. 8x forward), making it the more compelling value choice. Analysts rate AMN Healthcare Services, Inc. (AMN) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AMN or HCSG?
On forward P/E, AMN Healthcare Services, Inc.
is actually cheaper at 11. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — AMN or HCSG?
Over the past 5 years, Healthcare Services Group, Inc.
(HCSG) delivered a total return of -21. 1%, compared to -75. 1% for AMN Healthcare Services, Inc. (AMN). Over 10 years, the gap is even starker: HCSG returned -26. 8% versus AMN's -41. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AMN or HCSG?
By beta (market sensitivity over 5 years), AMN Healthcare Services, Inc.
(AMN) is the lower-risk stock at 1. 08β versus Healthcare Services Group, Inc. 's 1. 12β — meaning HCSG is approximately 4% more volatile than AMN relative to the S&P 500. On balance sheet safety, Healthcare Services Group, Inc. (HCSG) carries a lower debt/equity ratio of 5% versus 125% for AMN Healthcare Services, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AMN or HCSG?
By revenue growth (latest reported year), Healthcare Services Group, Inc.
(HCSG) is pulling ahead at 7. 1% versus -8. 5% for AMN Healthcare Services, Inc. (AMN). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to 35. 6% for AMN Healthcare Services, Inc.. Over a 3-year CAGR, HCSG leads at 2. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AMN or HCSG?
Healthcare Services Group, Inc.
(HCSG) is the more profitable company, earning 3. 2% net margin versus -3. 5% for AMN Healthcare Services, Inc. — meaning it keeps 3. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCSG leads at 2. 6% versus 1. 2% for AMN. At the gross margin level — before operating expenses — AMN leads at 22. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AMN or HCSG more undervalued right now?
On forward earnings alone, AMN Healthcare Services, Inc.
(AMN) trades at 11. 0x forward P/E versus 20. 8x for Healthcare Services Group, Inc. — 9. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HCSG: 9. 8% to $24. 50.
08Which pays a better dividend — AMN or HCSG?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is AMN or HCSG better for a retirement portfolio?
For long-horizon retirement investors, AMN Healthcare Services, Inc.
(AMN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 08)). Both have compounded well over 10 years (AMN: -41. 5%, HCSG: -26. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AMN and HCSG?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(AMN: 99.9% · HCSG: 6.6%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.